Biomedical foam
AssigneeStryker European Operations Holdings LLC
InventorsJohannes Jacobus Jacobs, Colin Stanley
Life of this patent
Estimating the term…
Abstract
The present disclosure provides a foam nasal dressing for topically administering an active agent to a nasal cavity and for absorbing fluid discharge. The foam nasal dressing comprises a foamed core portion and a foamed shell portion arranged such that the foamed core portion is at least partially disposed within the foamed shell portion. The foamed shell portion has a porosity of greater than 80% and comprises a first phase-separated polymer and an active agent. The foamed core portion comprises a second phase-separated polymer with the first and second phase-separated polymers being the same or different. The present disclosure also provides a method of forming the foam nasal dressing.
Claims13
A foam nasal dressing for topically administering a drug to a nasal cavity and for absorbing fluid discharge, the nasal dressing comprising:
- a foamed core portion comprising a first polyurethane, the foamed core portion including amorphous segments and crystalline segments, and a hemostatic agent;
- a foamed shell portion arranged such that the foamed core portion is disposed within the foamed shell portion, the foamed shell portion having a porosity of greater than 80% and comprising a second polyurethane, the foamed shell portion including amorphous segments and crystalline segments, wherein the first and second polyurethanes are the same or different;
- a drug disposed in the foamed shell portion;
- the nasal dressing having an elongate shape extending from a first end to a second end, the nasal dressing having a first half adjacent the first end and a second half adjacent the second end;
- and
- a foamed base portion at the second end with the foamed shell portion and the foamed core portion extending from the foamed base portion towards the first end, such that the foamed base portion and the foamed shell portion cooperate to encapsulate the foamed core portion and define an outer surface of the nasal dressing;
- wherein a weight of the drug in the first half of the foam nasal dressing is greater than a weight of the drug in the second half of the foam nasal dressing;
- and wherein the foamed base portion comprises the first polyurethane and is integral with the foamed core portion.
Dependencies are inferred from the claim text.